Escherichia coli in Iran: An Overview of Antibiotic Resistance: A Review Article

  • Hesam ALIZADE Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
Keywords: Escherichia coli, Antibiotic resistance, E. coli infections

Abstract

Abstract Background: Escherichia coli is the most prominent cause of infectious diseases that span from the gastrointestinal tract to extra-intestinal sites such as urinary tract infection, septicaemia, and neonatal meningitis. The emergence and spread of antibiotic resistance in E. coli is an increasing public health concern across the world. Rising resistance in E. coli isolates is also observed in Iran. This review summarizes the status of antibiotic resistance of E. coli isolates in Iran from 2007 to 2016. Methods: The data of the prevalence of E. coli antibiotic resistance were collected from databases such as Web of Science, PubMed, Scopus, Embase, Cochrane Library, Google Scholar and Scientific Information Database. Results: Antibiotic resistance in E. coli is on the rise. Conclusion: Prevalence of antibiotic resistance of E. coli varies from region to region in Iran.    

References

Gayathri D, Eramma NK, Devaraja TN (2012). New Delhi metallo beta-Lactamase; Incidence and threats. Int J Biol Med Res, 3: 1870–4.

WHO (1983). Antimicrobial resistance. Bull World Health Organ, 61: 383–94.

Piatti G, Mannini A, Balistreri M, Schito AM (2008). Virulence factors in urinary Escherichia coli strains: Phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol, 46: 480–7.

Alizade H, Ghanbarpour R, Aflatoonian MR (2014). Molecular study on diarrheagenic Escherichia coli pathotypes isolated from under 5 years old children in southeast of Iran. Asian Pac J Trop Dis, 4(Suppl 2): S813-S817.

Alizade H, Fallah F, Ghanbarpour R et al (2015). Genotyping of ESBL producing uropathogenic and diarrheagenic Escherichia coli in southeast of Iran. Infect Disord Drug Targets, 15: 118–24.

Barguigua A, El Otmani F, Talmi M et al (2011). Characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco. J Med Microbiol, 60 (Pt 9): 1344–52.

Ahmed OB, Omar AO, Asghar AH, Elhassan MM (2013). Prevalence of TEM, SHV and CTX-M genes in Escherichia coli and Klebsiella spp urinary isolates from Sudan with confirmed ESBL phenotype. Life Sci J, 10: 191–5.

Alizade H, Fallah F, Ghanbarpour R et al (2014). Phylotyping of blaCTX-M-15 gene in extended spectrum beta lactamase producing Escherichia coli isolates from clinical samples in Iran. Hum Vet Med, 6: 169–73.

Bradford P (2001). Extended spectrum beta lactamase in the 21 century: characterization, epidemiology, and detection of this important resistant threat. Clin Microbiol Rev, 14: 933–51.

Blair JMA, Webber MA, Baylay AJ et al (2015). Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol, 13: 42–51.

Bonomo RA (2011). New Delhi metallo-β-lactamase and multidrug resistance: A global SOS? Clin Infect Dis, 52: 485–7.

Kuntaman K, Lestari ES, Severin JA et al (2005). Fluoroquinolone-resistant Escherichia coli, Indonesia. Emerg Infect Dis, 11: 1363–9.

Poole K (2005). Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother, 49: 479–87.

Arabi H, Pakzad I, Nasrollahi A et al (2015). Sulfonamide resistance genes (sul) in extended spectrum beta lactamase (ESBL) and non-ESBL producing Escherichia coli isolated from Iranian hospitals. Jundishapur J Microbiol, 8: e19961.

Bean DC, Livermore DM, Hall LMC (2009). Plasmids imparting sulfonamide resistance in Escherichia coli: Implications for persistence. Antimicrob Agents Chemother, 53: 1088–93.

Huovinen P (2001). Resistance to trimethoprim-sulfamethoxazole. Clin Infect Dis, 32: 1608–14.

WHO (2015). Worldwide country situation analysis: response to antimicrobial resistance. http://apps.who.int/iris/bitstream/10665/163468/1/9789241564946_eng.pdf?ua=1&ua=1

Habibzadeh F (2013). Editor`s page use and misuse of antibiotics in the Middle East. Lancet, 382.

Sharifi A, Sharifi H, Karamouzian M et al (2013). Topical ocular anesthetic abuse among Iranian welders: time for action. Middle East Afr J Ophthalmol, 20: 336–40.

Moradi J, Hashemi FB, Bahador A (2015). Antibiotic resistance of Acinetobacter baumannii in Iran: A Systemic review of the published literature. Osong Public Health Res Perspect, 6: 79–86.

Kazemnia A, Ahmadi M, Dilmaghani M (2014). Antibiotic resistance pattern of different Escherichia coli phylogenetic groups isolated from human urinary tract infection and avian colibacillosis. Iran Biomed J, 18: 219–24.

Alikhani MY, Hashemi SH, Aslani MM, Farajnia S (2013). Prevalence and antibiotic resistance patterns of diarrheagenic Escherichia coli isolated from adolescents and adults in Hamedan, Western Iran. Iran J Microbiol, 5: 42–7.

Soltani J, Poorabbas B, Miri N, Mardaneh J (2016). Health care associated infections, antibiotic resistance and clinical outcome: A surveillance study from Sanandaj, Iran. World J Clin Cases, 4: 63–70.

Hosseini-Mazinani SM, Eftekhar F, Milani M, Ghandili S (2007). Characterization of β-lactamases from urinary isolates of Escherichia coli in Tehran. Iran Biomed J, 11: 95–9.

Najar Peerayeh S, Eslami M, Memariani M, Siadat SD (2013). High prevalence of blaCTX-M-1 group extended-spectrum β-lactamase genes in Escherichia coli isolates from Tehran. Jundishapur J Microbiol, 6: e6863.

Ahangarzadeh Rezaee M, Sheikhalizadeh V, Hasani A (2011). Detection of integrons among multi-drug resistant (MDR) Escherichia coli strains isolated from clinical specimens in northern west of Iran. Braz J Microbiol, 42: 1308–13.

Irajian G, Moghadas AJ (2010). Frequency of extended-spectrum beta lactamase positive and multidrug resistance pattern in Gram-negative urinary isolates, Semnan, Iran. Jundishapur J Microbiol, 3: 107–13.

Mohajeri P, Darfarin G, Farahani A (2014). Genotyping of ESBL producing uropathogenic Escherichia coli in West of Iran. Int J Microbiol, 2014:276941.

Issazadeh K, Naghibi SN, Khoshkholgh-pahlaviani MRM (2015). Drug resistance and serotyping of uropathogenic Escherichia coli among Patients with urinary tract infection in Rasht, Iran. Zahedan J Res Med Sci, 29–33.

Babaei Hemmati T, Mehdipour Moghaddam MJ, Salehi Z, Habibzadeh SM (2015). Prevalence of CTX-M-Type β-lactamases in multi-drug resistant Escherichia coli isolates from north of Iran, Rasht. Biol J Microorg, 3: 69–78.

Mehdipour Moghaddam MJ, Mirbagheri AA, Salehi Z, Habibzade SM (2015). Prevalence of class 1 integrons and extended spectrum beta lactamases among multi-drug resistant Escherichia coli isolates from north of Iran. Iran Biomed J, 19: 233–9.

Gashgi F, Zeighami H, Haghi F (2015). Frequency of E. coli clinical isolates producing blaSHV and blaTEM extended-spectrum beta-lactamases. Hormozgan Med J, 19: 218-224.

Mohammadi-Mehr M, Feizabadi M (2011). Antimicrobial resistance pattern of Gram-negative bacilli isolated from patients at ICUs of Army hospitals in Iran. Iran J Microbiol, 3: 26–30.

Safari M, Shojapour M, Akbari M, Pourbabaee A, Abtahi H (2013). Dissemination of CTX-M-type beta-lactamase among clinical isolates of Enterobacteriaceae in Markazi Province, Iran. Jundishapur J Microbiol, 6: e7182.

Kalantar D, Mansouri S (2010). Emergence of multiple β-lactamases produced by Escherichia coli clinical isolates from hospitalized patient in Kerman, Iran. Jundishapur J Microbiol, 3: 137–45.

Shams F, Hasani A, Ahangarzadeh Rezaee M et al (2015). Carriage of class 1 and 2 integrons in quinolone, extended-spectrum-β-lactamase-producing and multi drug resistant E. coli and K. pneumoniae: High burden of antibiotic resistance. Adv Pharm Bull, 5: 335–42.

Bush K, Jacoby GA (2010). Updated functional classification of beta-lactamases. Antimicrob Agents Chemother, 54: 969–76.

Sedighi I, Arabestani MR, Rahimbakhsh A et al (2015). Dissemination of extended-spectrum β-lactamases and quinolone resistance genes among clinical isolates of uropathogenic Escherichia coli in children. Jundishapur J Microbiol, 8: e19184.

Alizade H, Fallah F, Ghanbarpour R et al (2015). Phylogenetic groups, extended-spectrum beta-lactamases and metallo-beta-lactamase in Escherichia coli isolated from fecal samples of patients with diarrhea in Iran. Gastroenterol Hepatol Bed Bench, 8: 207–14.

Pakzad I, Ghafourian S, Taherikalani M et al (2011). qnr Prevalence in extended spectrum beta-lactamases (ESBLs) and none-ESBLs producing Escherichia coli isolated from urinary tract infections in central of Iran. Iran J Basic Med Sci, 14: 458–64.

Ghorbani-dalini S, Kargar M, Doosti A et al (2015). Molecular epidemiology of ESBL genes and multi-drug resistance in diarrheagenic Escherichia coli strains isolated from adults in Iran. Iran J Pharm Res, 14: 1257-62.

Heidary M, Momtaz H, Madani M (2014). Characterization of diarrheagenic antimicrobial resistant Escherichia coli isolated from pediatric patients in Tehran, Iran. Iran Red Crescent Med J, 16: e12329.

Shayan S, Bokaeian M, Shahraki S (2014). Prevalence and molecular characterization of AmpC-Producing clinical isolates of Escherichia coli from Southeastern Iran. Microb Drug Resist, 20: 104–7.

Khoshvaght H, Haghi F, Zeighami H (2014). Extended spectrum beta-lactamase producing Enteroaggregative Escherichia coli from young children in Iran. Gastroenterol Hepatol Bed Bench, 7: 131–6.

Shahcheraghi F, Ghezelgeh FR, Nobari S et al (2014). Identification and characterization of class 1 integrons among atypical enteropathogenic Escherichia coli isolated from children under 5 years of age. Iran J Microbiol, 6: 156–62.

Rashki A (2014). Cervico-vaginopathogenic Escherichia coli in Iran: Serogroup distributions, virulence factors and antimicrobial resistance properties. Microb Pathog, 75: 29–34.

Khoshbakht R, Salimi A, Shirzad Aski H, Keshavarzi H (2013). Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Karaj, Iran. Jundishapur J Microbiol, 6: 86–90.

Shams F, Hasani A, Pormohammad A et al (2014). qnrA implicated quinolone resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates from a University Teaching Hospital. Life Sci J, 11(12s): 1032–5.

Soleimani N, Aganj M, Ali L et al (2014). Frequency distribution of genes encoding aminoglycoside modifying enzymes in uropathogenic E. coli isolated from Iranian hospital. BMC Res Notes, 7: 842.

Momtaz H, Dehkordi FS, Hosseini MJ et al (2013). Serogroups, virulence genes and antibiotic resistance in Shiga toxin-producing Escherichia coli isolated from diarrheic and non-diarrheic pediatric patients in Iran. Gut Pathog, 5:39.

Mobaleghi J, Salimizand H, Beiranvand S et al (2012). Extended spectrum β-lactamases in urinary isolates of Escherichia coli in five Iranian hospitals. Asian J Pharm Clin Res, 5 (Suppl 2): 35–6.

Mirzarazi M, Rezatofighi SE, Pourmahdi M, Mohajeri MR (2013). Antibiotic resistance of isolated gram negative bacteria from urinary tract infections (UTIs) in Isfahan. Jundishapur J Microbiol, 6: e6883.

Neamati F, Firoozeh F, Saffari M, Zibaei M (2015). Virulence genes and antimicrobial resistance pattern in uropathogenic Escherichia coli isolated from hospitalized patients in Kashan, Iran. Jundishapur J Microbiol, 8: e17514.

Motallebi M, Piroozmand A, Rohani M et al (2011). Multiple drug resistance of enteropathogenic Escherichia coli isolated from children with diarrhea in Kashan, Iran. Afr J Microbiol Res, 5: 3305–9.

Nakhjavani FA, Mirsalehian A, Hamidian M et al (2007). Antimicrobial susceptibility testing for Escherichia coli strains to fluoroquinolones, in urinary tract infections. Iran J Public Health, 36: 89–92.

Zahraei Salehi T, Farashi Bonab S (2006). Antibiotics susceptibility pattern of Escherichia coli strains isolated from chickens with colisepticemia in Tabriz province, Iran. Int J Poult Sci, 5: 677–84.

Aslani MM, Salmanzadeh-ahrabi S, Alikhani YM et al (2008). Molecular detection and antimicrobial resistance of diarrheagenic Escherichia coli strains isolated from diarrheal cases. Saudi Med J, 29: 388-92.

Lavakhamseh H, Mohajeri P, Rouhi S et al (2016). Multidrug-resistant Escherichia coli strains isolated from patients are associated with class 1 and 2 integrons. Chemotherapy, 61: 72–6.

Gholipour A, Soleimani N, Shokri D et al (2014). Phenotypic and molecular characterization of extended-spectrum β-lactamase produced by Escherichia coli, and Klebsiella pneumoniae isolates in an educational hospital. Jundishapur J Microbiol, 7: e11758.

Harifi Mood E, Meshkat Z, Izadi N et al (2015). Prevalence of quinolone resistance genes among extended-spectrum β-lactamase-producing Escherichia coli in Mashhad, Iran. Jundishapur J Microbiol, 8: e16217.

Sedighi I, Solgi A, Amanati A, Alikhani MY (2014). Choosing the correct empirical antibiotic for urinary tract infection in pediatric: Surveillance of antimicrobial susceptibility pattern of Escherichia coli by E-Test method. Iran J Microbiol, 6: 387–91.

Farshad S, Japoni A, Hosseini M (2008). Low distribution of integrons among multidrug resistant E. coli strains isolated from children with community-acquired urinary tract infections in Shiraz, Iran. Pol J Microbiol, 57: 193–8.

Rezai MS, Salehifar E, Rafiei A et al (2015). Characterization of multidrug resistant extended-spectrum beta-lactamase-producing Escherichia coli among uropathogens of pediatrics in north of Iran. BioMed Res Int, 2015:309478.

Zahedi Bialvaei A, Samadi Kafil H (2015). Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin, 31: 707–21.

Mansouri S, Kalantar Neyestanaki D, Shokoohi M et al (2014). Characterization of AmpC, CTX-M and MBLs types of β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli producing extended spectrum β-lactamases in Kerman, Iran. Jundishapur J Microbiol, 7: e8756.

Seputiené V, Povilonis J, Ruzauskas M et al (2010). Prevalence of trimethoprim resistance genes in Escherichia coli isolates of human and animal origin in Lithuania. J Med Microbiol, 59 (Pt 3): 315–22.

Moghni M, Barati S (2013). Antibiotic resistance in food poisoning caused by Escherishia coli O157: H7 in hospitalized patients at 5 years in Iran. Res J Pharm Biol Chem Sci, 4: 436–42.

Momtaz H, Karimian A, Madani M et al (2013). Uropathogenic Escherichia coli in Iran: serogroup distributions, virulence factors and antimicrobial resistance properties. Ann Clin Microbiol Antimicrob, 12: 8.

Karami N, Nowrouzian F, Adlerberth I, Wold AE (2006). Tetracycline resistance in Escherichia coli and persistence in the infantile colonic microbiota. Antimicrob Agents Chemother, 50: 156–61.

Centers for Disease Control and Prevention (2013). Antibiotic resistance threats in the United States (2013). https://www.cdc.gov/drugresistance/threat-report-2013/index.html

Ferdosi Shahandashti E, Javanian M, Mora-dian-Kouchaksaraei M et al (2015). Re-sistance patterns of Escherichia coli causing urinary tract infection. Caspian J Intern Med, 6: 148-51.

Kalantar E, Soheili F, Salimi H, Soltan Dallal MM (2011). Frequency, antimicrobial sus-ceptibility and plasmid profiles of Esche-richia coli pathotypes obtained from chil-dren with acute diarrhea. Jundishapur J Mi-crobiol, 4: 23-8.

Hemati Z, Ghanbarpour R, Alizade H (2014). The distribution of beta lactamase genes in Escherichia coli phylotypes isolated from diarrhea and UTI cases in northwest Iran. Adv Clin Exp Med, 23: 523–9.

Khorshidi A, Rohani M, Akbari M, Motal-lebi M (2013). Molecular detection of blaTEM and blaSHV genes among clini-cal isolates of Escherichia coli from Kashan, Iran. Afr J Microbiol Res, 7: 751-4.

Sadat Moini A, Soltani B, Taghavi Ardakani A et al (2015). Multidrug-resistant Esche-richia coli and Klebsiella pneumoniae isolated from patients in Kashan, Iran. Jundishapur J Microbiol, 8: e27517.

Moayednia R, Shokri D, Mobasherizadeh S et al (2014). Frequency assessment of β-lactamase enzymes in Escherichia coli and Klebsiella isolates in patients with urinary tract infection. J Res Med Sci, 19(Suppl 1):S41-5.

Asadi S, Kargar M, Solhjoo K et al (2014). The association of virulence determinants of uropathogenic Escherichia coli with anti-biotic resistance. Jundishapur J Microbiol, 7: e9936.

Khoramrooz SS, Sharifi A, Yazdanpanah M et al (2016). High frequency of class 1 integrons in Escherichia coli isolated from patients with urinary tract infections in Yasuj, Iran. Iran Red Crescent Med J, 18: e26399.

Adib N, Ghanbarpour R, Solatzadeh H, Alizade H (2014). Antibiotic resistance profile and virulence genes of uropathogenic Escherichia coli isolates in relation to phylogeny. Trop Biomed, 31: 17-25.

Ayatollahi J, Vahidi A, Shahcheraghi SH et al (2013). Investigating the resistance of Escherichia coli against some selected anti-microbials in Bam. Jundishapur J Microbiol, 6: e7407.

Javadian F, Sepehri Z, Khaje H et al (2014). Detection, susceptibility and molecular characterisation of ESBL-producing E. coli causing urinary tract infection. J Bio Env Sci, 5: 291-9.

Memariani M, S Najar-Peerayeh, Salehi TZ, Mostafavi SKS (2015). Occurrence of SHV, TEM and CTX-M β-lactamase genes among enteropathogenic Escherichia coli strains isolated from children with diarrhea. Jundishapur J Microbiol, 8: e15620.

Kargar M, Mohammadalipour Z, Doosti A et al (2014). High prevalence of class 1 to 3 integrons among multidrug-resistant diarrheagenic Escherichia coli in southwest of Iran. Osong Public Health Res Perspect, 5: 193–8.

Published
2017-12-31
How to Cite
1.
ALIZADE H. Escherichia coli in Iran: An Overview of Antibiotic Resistance: A Review Article. IJPH. 47(1):1-2.
Section
Review Article(s)